NARA Discovery
Article Details
← Back to Search Results
Journal Article

Analysis of genetic risk factors for Leber hereditary optic neuropathy in the Polish population

Julia Sikorska; Maciej R. Krawczyński; Magdalena Korwin; Monika Ołdak; Ewa Bartnik; Katarzyna Tońska; Agnieszka Piotrowska-Nowak
Journal of Applied Genetics · 2026

Abstract

Leber hereditary optic neuropathy (LHON) is primarily caused by pathogenic mitochondrial DNA (mtDNA) variants, most commonly the m.11778G>A variant in the MT-ND4 gene. The presence of this variant alone is insufficient to trigger disease symptoms, of which vision loss is the hallmark. Given the incomplete penetrance and inter-population variability in modifying factors, this study aimed to investigate two previously proposed genetic risk factors for LHON in the Polish population. Using quantitative PCR, we measured the mtDNA copy number in peripheral blood of affected and unaffected carriers of the m.11778G>A variant. In addition, we assessed the frequency of the PRICKLE3 c.157C>T variant in symptomatic, asymptomatic and control individuals using PCR-RFLP. Our results indicate that mtDNA copy number was not associated with LHON symptom manifestation in the Polish cohort under conditions tested, in contrast to previously reported associations in other populations. In addition, the PRICKLE3 c.157C>T variant was absent in our cohort, indicating that it is not a common modifier of LHON penetrance in the Polish population. These findings suggest that the incomplete penetrance of LHON in the Polish population may involve other modifying factors, such as yet unidentified nuclear DNA variants.

Bibliographic Information

JournalJournal of Applied Genetics
PublisherSpringer
Publication Date2026-06-27
Publication Year2026
Document TypeJournal Article
Print ISSN1234-1983
eISSN2190-3883
DOI10.1007/s13353-026-01090-7

Access Information

NARA Access Coverage2006-01-01~Current
Journal Homepagehttps://www.springer.com/journal/13353
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.